GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » EV-to-Revenue

Novonesis AS (Novonesis AS) EV-to-Revenue : 10.38 (As of Apr. 27, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Novonesis AS's enterprise value is $26,885 Mil. Novonesis AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2,590 Mil. Therefore, Novonesis AS's EV-to-Revenue for today is 10.38.

The historical rank and industry rank for Novonesis AS's EV-to-Revenue or its related term are showing as below:

NVZMY' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.38   Med: 6.54   Max: 10.3
Current: 10.38

During the past 13 years, the highest EV-to-Revenue of Novonesis AS was 10.30. The lowest was 4.38. And the median was 6.54.

NVZMY's EV-to-Revenue is ranked worse than
94.22% of 1539 companies
in the Chemicals industry
Industry Median: 1.53 vs NVZMY: 10.38

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-27), Novonesis AS's stock price is $55.76. Novonesis AS's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $9.32. Therefore, Novonesis AS's PS Ratio for today is 5.98.


Novonesis AS EV-to-Revenue Historical Data

The historical data trend for Novonesis AS's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS EV-to-Revenue Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.57 6.91 9.94 5.89 6.14

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.89 5.43 4.95 4.40 6.14

Competitive Comparison of Novonesis AS's EV-to-Revenue

For the Specialty Chemicals subindustry, Novonesis AS's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS's EV-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Novonesis AS's EV-to-Revenue falls into.



Novonesis AS EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Novonesis AS's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=26885.314/2589.785
=10.38

Novonesis AS's current Enterprise Value is $26,885 Mil.
Novonesis AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,590 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis AS  (OTCPK:NVZMY) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Novonesis AS's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=55.76/9.317
=5.98

Novonesis AS's share price for today is $55.76.
Novonesis AS's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.32.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis AS EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Novonesis AS's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023

Not Just Yogurt Anymore

By PRNewswire 10-26-2023

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019